Interferon plus vinblastine in renal carcinoma patients who had failed on interferon alone

O Merimsky et al. Eur J Cancer. 1990.

. 1990;26(8):921.

doi: 10.1016/0277-5379(90)90204-7.

No abstract available

Similar articles

Prediction of objective response to recombinant interferon-alpha with or without vinblastine in metastatic renal cell carcinoma.
Fosså SD, Nesland JM, Melvik JE, Jacobsen AB, Moe B. Fosså SD, et al. Acta Oncol. 1990;29(3):303-6. doi: 10.3109/02841869009090002. Acta Oncol. 1990. PMID: 2363942
Does vinblastine add to the potency of alpha interferon in the treatment of renal cell carcinoma?
Merimsky O, Shnider BI, Chaitchik S. Merimsky O, et al. Mol Biother. 1991 Mar;3(1):34-7. Mol Biother. 1991. PMID: 2069758 Clinical Trial.
Combined interferon and vinblastine treatment in advanced renal cell cancer.
Kellokumpu-Lehtinen P, Jantunen I, Flander M, Johansson R, Nordman E. Kellokumpu-Lehtinen P, et al. Acta Oncol. 1995;34(7):975-7. doi: 10.3109/02841869509127219. Acta Oncol. 1995. PMID: 7492395 Clinical Trial. No abstract available.
Interferon treatment of renal cell carcinoma. Current status and future prospects.
Krown SE. Krown SE. Cancer. 1987 Feb 1;59(3 Suppl):647-51. doi: 10.1002/1097-0142(19870201)59:3+<647::aid-cncr2820591313>3.0.co;2-#. Cancer. 1987. PMID: 10822464 Review.
[The medical treatment of renal cancer in adults].
Sculier JP. Sculier JP. Rev Med Brux. 1989 May;10(5):190-6. Rev Med Brux. 1989. PMID: 2662317 Review. French.